Atrial fibrillation was diagnosed in 477 of 1,501 (31.8%) participants in the monitoring group and 550 of 4,503 (12.2%) participants in the control group (HR 3.17, 95% CI 2.81-3.59, P<0.001), reported ...

July 14--A device a fraction of an inch long is providing George Saenz with a peace of mind he has never had before. Three weeks ago, the 67-year-old independent insurance agent had the Medtronic ...

Atrial fibrillation is a type of arrhythmia that causes an irregular or abnormally fast heart rate. It is the most common arrhythmia. When someone has atrial fibrillation, the upper chambers of their ...

Remote monitoring devices like insertable cardiac monitors have already massively cut down on the amount of time that clinicians must spend actively tracking patients’ conditions—but French startup ...

Most of the best Fitbit trackers and Google Pixel Watch models feature accurate heart rate monitors. These little sensors provide valuable insight into our ticker’s rhythm when resting or on the go, ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.